Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.
Stoke Therapeutics Inc is engaged in addressing the underlying causes of severe diseases by upregulating protein expression with RNA-based medicines. Using its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, it is developing antisense oligonucleotides (ASOs) to selectively... Stoke Therapeutics Inc is engaged in addressing the underlying causes of severe diseases by upregulating protein expression with RNA-based medicines. Using its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, it is developing antisense oligonucleotides (ASOs) to selectively restore protein levels. Mostra di più
| Periodo † | Var | Var % | Apert. | Max | Min | Med. Vol. Giorn. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -1.98 | -23.9419588875 | 8.27 | 8.34 | 6.1 | 1035019 | 7.31696626 | CS |
| 4 | -1.05 | -14.3051771117 | 7.34 | 9.035 | 6.1 | 881171 | 8.04070275 | CS |
| 12 | -3.53 | -35.9470468432 | 9.82 | 12.98 | 6.1 | 880002 | 9.16361037 | CS |
| 26 | -5.96 | -48.6530612245 | 12.25 | 14.72 | 6.1 | 710714 | 10.514208 | CS |
| 52 | -6.93 | -52.4205748865 | 13.22 | 17.58 | 6.1 | 712721 | 12.13551429 | CS |
| 156 | -14.93 | -70.3581526861 | 21.22 | 24.97 | 3.35 | 485421 | 11.14235233 | CS |
| 260 | -15.51 | -71.1467889908 | 21.8 | 71.58 | 3.35 | 360514 | 15.1014959 | CS |
Le azioni che visualizzerai appariranno in questo riquadro, così potrai facilmente tornare alle quotazioni di tuo interesse.
Assistenza: support@advfn.it
Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni
Caratteristiche principali
Premium
